Measuring quality in arthritis care: The arthritis foundation's quality indicator set for analgesics

Kenneth G. Saag, Jason J. Olivieri, Fausto Patino, Ted R Mikuls, Jeroan J. Allison, Catherine H. MacLean

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

Objective. To develop systematically validated quality indicators (QIs) addressing analgesic safety. Methods. A comprehensive literature review of existing quality measures, clinical guidelines, and evidence supporting potential QIs concerning nonselective (traditional) nonsteroidal anti-inflammatory drugs (NSAIDs) and newer cyclooxygenase 2-selective NSAIDs was undertaken. An expert panel then validated or refuted potential indicators utilizing a proven methodology. Results. Eleven potential QIs were proposed. After panel review, 8 were judged to be valid; an additional 10 were proposed by the panel, of which 7 were rated as valid. Quality indicators focused upon informing patients about risk, NSAID choice and gastrointestinal prophylaxis, and side effect monitoring. Conclusion. The 15 validated indicators were combined, where appropriate, to yield 10 validated processes of care indicators for the safe use of NSAIDs. These indicators developed by literature review and finalized by our expert panel process can serve as a basis to compare the quality of analgesic use provided by health care providers and delivery systems.

Original languageEnglish (US)
Pages (from-to)337-349
Number of pages13
JournalArthritis Care and Research
Volume51
Issue number3
StatePublished - Jun 15 2004

Fingerprint

Arthritis
Analgesics
Anti-Inflammatory Agents
Pharmaceutical Preparations
Gastrointestinal Agents
Cyclooxygenase 2
Health Personnel
Guidelines
Delivery of Health Care
Safety

Keywords

  • Analgesics
  • NSAIDs
  • Patient safety
  • Quality indicators

ASJC Scopus subject areas

  • Rheumatology

Cite this

Saag, K. G., Olivieri, J. J., Patino, F., Mikuls, T. R., Allison, J. J., & MacLean, C. H. (2004). Measuring quality in arthritis care: The arthritis foundation's quality indicator set for analgesics. Arthritis Care and Research, 51(3), 337-349.

Measuring quality in arthritis care : The arthritis foundation's quality indicator set for analgesics. / Saag, Kenneth G.; Olivieri, Jason J.; Patino, Fausto; Mikuls, Ted R; Allison, Jeroan J.; MacLean, Catherine H.

In: Arthritis Care and Research, Vol. 51, No. 3, 15.06.2004, p. 337-349.

Research output: Contribution to journalReview article

Saag, KG, Olivieri, JJ, Patino, F, Mikuls, TR, Allison, JJ & MacLean, CH 2004, 'Measuring quality in arthritis care: The arthritis foundation's quality indicator set for analgesics', Arthritis Care and Research, vol. 51, no. 3, pp. 337-349.
Saag, Kenneth G. ; Olivieri, Jason J. ; Patino, Fausto ; Mikuls, Ted R ; Allison, Jeroan J. ; MacLean, Catherine H. / Measuring quality in arthritis care : The arthritis foundation's quality indicator set for analgesics. In: Arthritis Care and Research. 2004 ; Vol. 51, No. 3. pp. 337-349.
@article{d1662be766b64df5b2824fcc60d6b8d9,
title = "Measuring quality in arthritis care: The arthritis foundation's quality indicator set for analgesics",
abstract = "Objective. To develop systematically validated quality indicators (QIs) addressing analgesic safety. Methods. A comprehensive literature review of existing quality measures, clinical guidelines, and evidence supporting potential QIs concerning nonselective (traditional) nonsteroidal anti-inflammatory drugs (NSAIDs) and newer cyclooxygenase 2-selective NSAIDs was undertaken. An expert panel then validated or refuted potential indicators utilizing a proven methodology. Results. Eleven potential QIs were proposed. After panel review, 8 were judged to be valid; an additional 10 were proposed by the panel, of which 7 were rated as valid. Quality indicators focused upon informing patients about risk, NSAID choice and gastrointestinal prophylaxis, and side effect monitoring. Conclusion. The 15 validated indicators were combined, where appropriate, to yield 10 validated processes of care indicators for the safe use of NSAIDs. These indicators developed by literature review and finalized by our expert panel process can serve as a basis to compare the quality of analgesic use provided by health care providers and delivery systems.",
keywords = "Analgesics, NSAIDs, Patient safety, Quality indicators",
author = "Saag, {Kenneth G.} and Olivieri, {Jason J.} and Fausto Patino and Mikuls, {Ted R} and Allison, {Jeroan J.} and MacLean, {Catherine H.}",
year = "2004",
month = "6",
day = "15",
language = "English (US)",
volume = "51",
pages = "337--349",
journal = "Arthritis and Rheumatism",
issn = "2151-4658",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Measuring quality in arthritis care

T2 - The arthritis foundation's quality indicator set for analgesics

AU - Saag, Kenneth G.

AU - Olivieri, Jason J.

AU - Patino, Fausto

AU - Mikuls, Ted R

AU - Allison, Jeroan J.

AU - MacLean, Catherine H.

PY - 2004/6/15

Y1 - 2004/6/15

N2 - Objective. To develop systematically validated quality indicators (QIs) addressing analgesic safety. Methods. A comprehensive literature review of existing quality measures, clinical guidelines, and evidence supporting potential QIs concerning nonselective (traditional) nonsteroidal anti-inflammatory drugs (NSAIDs) and newer cyclooxygenase 2-selective NSAIDs was undertaken. An expert panel then validated or refuted potential indicators utilizing a proven methodology. Results. Eleven potential QIs were proposed. After panel review, 8 were judged to be valid; an additional 10 were proposed by the panel, of which 7 were rated as valid. Quality indicators focused upon informing patients about risk, NSAID choice and gastrointestinal prophylaxis, and side effect monitoring. Conclusion. The 15 validated indicators were combined, where appropriate, to yield 10 validated processes of care indicators for the safe use of NSAIDs. These indicators developed by literature review and finalized by our expert panel process can serve as a basis to compare the quality of analgesic use provided by health care providers and delivery systems.

AB - Objective. To develop systematically validated quality indicators (QIs) addressing analgesic safety. Methods. A comprehensive literature review of existing quality measures, clinical guidelines, and evidence supporting potential QIs concerning nonselective (traditional) nonsteroidal anti-inflammatory drugs (NSAIDs) and newer cyclooxygenase 2-selective NSAIDs was undertaken. An expert panel then validated or refuted potential indicators utilizing a proven methodology. Results. Eleven potential QIs were proposed. After panel review, 8 were judged to be valid; an additional 10 were proposed by the panel, of which 7 were rated as valid. Quality indicators focused upon informing patients about risk, NSAID choice and gastrointestinal prophylaxis, and side effect monitoring. Conclusion. The 15 validated indicators were combined, where appropriate, to yield 10 validated processes of care indicators for the safe use of NSAIDs. These indicators developed by literature review and finalized by our expert panel process can serve as a basis to compare the quality of analgesic use provided by health care providers and delivery systems.

KW - Analgesics

KW - NSAIDs

KW - Patient safety

KW - Quality indicators

UR - http://www.scopus.com/inward/record.url?scp=2642546648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2642546648&partnerID=8YFLogxK

M3 - Review article

C2 - 15188317

AN - SCOPUS:2642546648

VL - 51

SP - 337

EP - 349

JO - Arthritis and Rheumatism

JF - Arthritis and Rheumatism

SN - 2151-4658

IS - 3

ER -